IPO

A key safety milestone for Opus Genetics' OPGx-BEST1 gene therapy trial offers a glimmer of hope for thousands facing progressive vision loss from Best disease.

Once mired in debt, Castellum has secured over $170M in prime contracts, signaling a dramatic resurgence in the competitive federal defense market.

A $900k stock grant to a new exec reveals more than a salary. It's a look into biotech's talent war and the financial tools used to secure human assets.

Insiders at the newly independent Magnum Ice Cream Company show major confidence with multi-million-euro share buys following its spin-off from Unilever.

A landmark deal for two Airbus A321neos signals more than fleet expansion; it's a strategic play to turn Tashkent into the next major East-West air hub.

A routine regulatory filing reveals Sintana Energy's major M&A play. We decode the signals, the Challenger deal, and what it means for its oil future.

Netcapital's huge 1M share grant to its new CEO is a high-stakes play. We decode the strategy, the risk, and the ambitious revenue targets.

Guangdong Jiaying Pharma is leveraging its unique Hakka heritage to enter the global market. But can ancient wisdom navigate modern regulatory and corporate hurdles?

Broadway star Morgan Dudley returns to the tech platform that discovered her. Can her insider role help Stargaze win the high-stakes talent-tech race?

With its AI & Autonomy Day, Rivian is betting its future on software. Investors are watching to see if its tech can deliver a true competitive edge.

Broadway star Morgan Dudley returns to the tech platform that discovered her, a high-stakes move for Stargaze's bid to reshape talent discovery.

Following a major clinical trial win, Kymera Therapeutics seeks $500M. We break down the high-stakes strategy behind funding a new era of medicine.

A junior miner's historic regulatory win in Oregon could set a new precedent for resource development, balancing economic promise with environmental rigor.

Latham Group hires building products veteran Sean Gadd to lead its next wave of growth. Can a playbook that dominated fiber cement convert the pool industry?

Global X's Bitcoin ETFs promise hefty semi-monthly payouts. But is this crypto-generated income a golden opportunity or a high-stakes volatility gamble?

Beyond the lavish anniversary party, the Chinese spirits giant is leveraging a century of history in a sophisticated bid to conquer the Western market.

After teetering on the edge of delisting, cbdMD has regained NYSE compliance. A deep dive into the strategic financial moves that saved its market standing.

An Amazon e-commerce firm is making a high-stakes leap into homeland security. Can new leadership and disruptive AI tech transform the company's future?

Priority Technology's chairman wants to take the firm private at a premium, but a special committee and vocal investors are now weighing the offer.

As the humanoid robotics market soars towards $7.7B, one firm is recruiting top talent to find the next big winner. What does this move signal to investors?